drugset / Trial / NCT00401375

Study of Intravenous (IV) Methylnaltrexone Bromide (MNTX) in the Treatment of Post-Operative Ileus (POI)

NCT00401375

RandomizedParallel-groupQuadruple-blindTreatment

Summary

To evaluate the safety and efficacy of MNTX in participants who have undergone segmental colectomy and to assess if the time between the end of surgery and the first bowel movement is significantly shorter in the MNTX regimen than the equivalent assessment using a placebo regimen.

Timeline

Start
2006-10-31
Primary completion
2008-02-29
Completion
2008-02-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylnaltrexone Other / unclassified 12 mg Intravenous
Subject Methylnaltrexone Other / unclassified 24 mg Intravenous

Indications